Back to List
Quality0 Views

Decision & Action-Item Log — GLPI-103 Program

July 12, 2026

📚 Part of the GLPI-103 Regulatory Dossier — Reader's Guide. This article shows the live document; edits to the source appear here automatically.

🧪
Mock / simulation document

This is a mock / simulation document, made for a portfolio and for learning. The drug (GLPI-103), the sponsor, the people, and the data are all fictional. It is not a real regulatory submission and has no clinical, legal, or regulatory standing. What is real is the shape of the thing — the document structure, the standards it follows, and the analysis methods; the content inside is illustrative.

📄
About this document — a plain-language guide

What it is. The decision and action-item log — the record of key program decisions and their rationale.

Why it exists. Reviewers and auditors ask why choices were made. A decision log captures the rationale, alternatives, and owner for significant decisions, creating a defensible audit trail.

How it is produced here. It is a quality record: a plan or log that shows how the program controls quality and builds the audit trail sitting behind every other document.

Format & governing standard. Project governance (audit trail)


Decision & Action-Item Log — GLPI-103 Program

FieldValue
Document IDPM-DECISION
Version1.0
StandardProject governance (audit trail)
ConfidentialityConfidential

Records key governance decisions and their rationale (complements PM-004 Risk Register and QA-ISSUE).

Change History

VersionDateAuthorSummary
1.02026-06-29Project ManagementInitial log

Decision Log

IDDateDecisionRationaleOwner
DEC-0012026-06-29Document actual enrollment (900), not planned 900Realistic under-enrollment; honest reportingRA/Biostat
DEC-0022026-06-29Right-size early-phase N (SAD 40 / MAD 40 / Ph2 240)Early-phase N driven by dose-levels×cohort, not power; cost/ethics (PM-003)Clinical/PM
DEC-0032026-06-29Ground demographics in Nemotron-Personas-Korea + T2DM prevalenceRealistic Korean T2DM populationBiostat
DEC-0042026-06-29Map Korean SC values to English CDISC CTXPORT encoding + submission standardDM
DEC-0052026-06-29No REMS for FDA; labeling-based risk managementClass precedent; risks manageable by labelingRA-US/PV
DEC-0062026-06-29Substitute subset CDISC validator for headless Pinnacle 21P21 registration-gated GUI; honest alternative + manual stepsDM/QA

Action Items

IDActionOwnerDueStatus
ACT-001Run official Pinnacle 21 and append report (SDRG §6)DMTBDOpen
ACT-002Populate M4 nonclinical study reports beyond stubsNonclinicalTBDOpen

Comments (0)

No comments yet. Be the first to say something!